Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02296450 · ClinicalTrials.gov registry record
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
A clinical trial of Cancer and Dermatologic Conditions, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 1,025
- Enrollment target
- 4
- Study locations
NCT02296450 is a study of Cancer and Dermatologic Conditions that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,025 participants, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (71% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT02296450, a study of Cancer and Dermatologic Conditions, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 1,025 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to see how skin conditions that are related to different kinds of cancer or cancer treatments affect a patient's overall well-being. Skin conditions are common in cancer patients and survivors. Sometimes, the skin condition is directly related to the cancer. Other times, these conditions are a side effect of cancer treatment. Patients in the study will be asked to fill out at least one questionnaire about how they feel about their skin condition. If the patient needs to be treated for their skin condition, they will be asked to complete the same questionnaire when they return for a follow-up visit. The investigators hope the study will improve our understanding of how cancer patients feel about their skin conditions. They also hope this study helps them learn how to improve the way we treat skin conditions in cancer patients.
Conditions Studied
Interventions
- BEHAVIORAL Quality of Life (QoL) Assessment
Study Locations (4)
New York
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Suffolk- Hauppauge - Hauppauge
- Memorial Sloan Kettering Cancer Center - New York
New Jersey
- Memorial Sloan Kettering Cancer Center - Basking Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,025 participants |
| Start Date | 2014-11-18 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02296450
The ClinicalTrials.gov registry entry for NCT02296450 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,025 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,489-participant average among 615 other Cancer trials with a reported enrollment target (71% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Quality of Life (QoL) Assessment is the first listed.
NCT02296450 reports 4 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02296450 about?
NCT02296450 is a clinical study titled "Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments". The purpose of this study is to see how skin conditions that are related to different kinds of cancer or cancer treatments affect a patient's overall well-being. Skin conditions are common in cancer patients and survivors. Sometimes, the skin condition is directly related to the cancer. Other times,...
What is the current status of trial NCT02296450?
This trial is currently recruiting. The enrollment target is 1,025 participants. The study started on 2014-11-18. Estimated completion is 2026-11.
What conditions does trial NCT02296450 study?
This clinical trial studies the following conditions: Cancer, Dermatologic Conditions.
What interventions are being tested in trial NCT02296450?
The interventions under investigation include: Quality of Life (QoL) Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02296450?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02296450 being conducted?
This trial has 4 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.